✦ LIBER ✦

Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial

✍ Scribed by Mateos, M.-V.; Oriol, A.; Martinez-Lopez, J.; Gutierrez, N.; Teruel, A.-I.; Lopez de la Guia, A.; Lopez, J.; Bengoechea, E.; Perez, M.; Polo, M.; Palomera, L.; de Arriba, F.; Gonzalez, Y.; Hernandez, J.-M.; Granell, M.; Bello, J.-L.; Bargay, J.; Penalver, F.-J.; Ribera, J.-M.; Martin-Mateos, M.-L.; Garcia-Sanz, R.; Lahuerta, J.-J.; Blade, J.; San-Miguel, J. F.

Book ID: 115439673
Publisher: American Society of Hematology
Year: 2012
Tongue: English
Weight: 269 KB
Volume: 120
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2012-05-427815

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bortezomib, melphalan, and prednisone ve

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial

✍ María-Victoria Mateos; Albert Oriol; Joaquín Martínez-López; Norma Gutiérrez; An 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 255 KB

Bortezomib plus intermediate-dose dexame

Bortezomib plus intermediate-dose dexamethasone and thalidomide in elderly untreated patients with multiple myeloma: A Chinese experience

✍ Hongfeng Guo; Xin Zhou; Yuanqiang Jiang; Guohua Yang; Chao Sun; Yun Zhuang; Hong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

Oral melphalan and prednisone chemothera

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

✍ Antonio Palumbo; Sara Bringhen; Tommaso Caravita; Emanuela Merla; Vincenzo Cappa 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 114 KB

“Short Course” Bortezomib plus Melphalan

“Short Course” Bortezomib plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Nontransplant Candidates in Patients with Previously Untreated Multiple Myeloma

✍ Cristina Gasparetto; Jon P. Gockerman; Louis F. Diehl; Carlos M. de Castro; Jose 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 382 KB

Bortezomib Plus Melphalan and Prednisone

Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial

✍ Mateos, M. V.; Richardson, P. G.; Schlag, R.; Khuageva, N. K.; Dimopoulos, M. A. 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 493 KB

PSY19 THE COST-EFFECTIVENESS OF BORTEZOM

PSY19 THE COST-EFFECTIVENESS OF BORTEZOMIB PLUS MELPHALAN AND PREDNISONE VERSUS LENALIDOMIDE PLUS MELPHALAN AND PREDNISONE WITH CONTINUOUS LENALIDOMIDE MAINTENANCE TREATMENT FOR THE INITIAL TREATMENT OF MULTIPLE MYELOMA IN THE UNITED STATES

✍ S.T. Wang; H. Huang; A. Ba-mancini; H. Shi; K. Chen; C. Korves; R. Dhawan; A. Ca 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB